These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 2996654)
1. [Effect of 4-aminopyridine on the development of experimental botulism]. Morrison VV; Kryzhanovskiĭ GN Biull Eksp Biol Med; 1985 Oct; 100(10):445-7. PubMed ID: 2996654 [TBL] [Abstract][Full Text] [Related]
3. The action of batulinum toxin at the neuromuscular junction. Sellin LC Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105 [TBL] [Abstract][Full Text] [Related]
4. Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E, or F. Siegel LS; Johnson-Winegar AD; Sellin LC Toxicol Appl Pharmacol; 1986 Jun; 84(2):255-63. PubMed ID: 3715874 [TBL] [Abstract][Full Text] [Related]
5. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism. Simpson LL Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675 [TBL] [Abstract][Full Text] [Related]
6. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism. Siegel LS; Price JI Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299 [TBL] [Abstract][Full Text] [Related]
7. Cure of experimental botulism and antibotulismic effect of toosendanin. Shi YL; Wang ZF Acta Pharmacol Sin; 2004 Jun; 25(6):839-48. PubMed ID: 15169642 [TBL] [Abstract][Full Text] [Related]
8. Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin. Molgó J; Lemeignan M; Thesleff S Muscle Nerve; 1987 Jun; 10(5):464-70. PubMed ID: 3497343 [TBL] [Abstract][Full Text] [Related]
9. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction. Thomsen RH; Wilson DF J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556 [TBL] [Abstract][Full Text] [Related]
10. [Alterations in activity of the ATPase systems in subcellular fractions of brain and spinal cord in the preclinical period of botulinum poisoning]. Chesnokova NP; Nevvazhaĭ TA Vopr Med Khim; 1983; 29(1):107-10. PubMed ID: 6220517 [TBL] [Abstract][Full Text] [Related]
12. Botulism and vaccines for its prevention. Smith LA Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283 [TBL] [Abstract][Full Text] [Related]
13. Outbreaks of type C botulism in waterfowl in Japan. Ono T; Azuma R; Kato T; Takeuchi S; Suto T Natl Inst Anim Health Q (Tokyo); 1982; 22(3):102-14. PubMed ID: 6761593 [TBL] [Abstract][Full Text] [Related]
14. The immunization of broiler chickens against type C botulism. Dohms JE; Allen PH; Cloud SS Avian Dis; 1982; 26(2):340-5. PubMed ID: 7049149 [TBL] [Abstract][Full Text] [Related]
15. Effect of taurine on seizures induced by 4-aminopyridine. Pasantes-Morales H; Arzate ME J Neurosci Res; 1981; 6(4):465-74. PubMed ID: 7299851 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of impairment of energy metabolism in respiratory muscles in experimental botulism]. Morrison VV Vopr Med Khim; 1985; 31(3):64-7. PubMed ID: 4024533 [TBL] [Abstract][Full Text] [Related]
17. [Effect of botulinus toxin on oxygen utilization in different types of skeletal muscles]. Chesnokova NP; Alaeva IV; Astaf'eva OG Vopr Med Khim; 1980; 26(5):612-6. PubMed ID: 7423875 [TBL] [Abstract][Full Text] [Related]
18. Botulism among penned pheasants and protection by vaccination with C1 toxoid. Kurazono H; Shimozawa K; Sakaguchi G; Takahashi M; Shimizu T; Kondo H Res Vet Sci; 1985 Jan; 38(1):104-8. PubMed ID: 3883454 [TBL] [Abstract][Full Text] [Related]
19. Effective treatment of verapamil intoxication with 4-aminopyridine in the cat. Agoston S; Maestrone E; van Hezik EJ; Ket JM; Houwertjes MC; Uges DR J Clin Invest; 1984 May; 73(5):1291-6. PubMed ID: 6538884 [TBL] [Abstract][Full Text] [Related]
20. [Human botulinic intoxication due to Clostridium botulinum B]. González C; Gutiérrez C Ann Inst Pasteur (Paris); 1972 Dec; 123(6):799-803. PubMed ID: 4570334 [No Abstract] [Full Text] [Related] [Next] [New Search]